Temporarily, we can't deliver this item to USA. Contaсt us for more details.
Mastebolin (vial) is the vial containing the injectable form of hormone Drostanolone Propionate that is produced by Alpha-Pharma Healthcare. It was reflected as one of the finest therapeutic agents for about two decades. It is very effective in curing postmenopausal females having championship bodybuilding breast cancer. Latterly, it befitted extremely popular among the athletes and bodybuilders as a cutting steroid. They can use Mastebolin vial for their contest or competition preparation.
Mastebolin (vial) upsurges the metabolic rate of the body due to which fat burning rate is also maximized to great extent. The overall body temperature is also increased due to which the fat burning process is enhanced in the body. The reduction in body fat results in generating more lean muscles and you can develop some quality lean muscle mass and attain a perfectly ripped and toned body in a very short period of time. That is why bodybuilders use it in their cutting cycle.
Mastebolin (vial) is not so effective in the bulking cycle because the effect is mild and the gains are short term and weak. So you should avoid Mastebolin in bulking cycle and take any other bulking steroid for better results.
Side Effects Mastebolin (vial)
There are many side effects associated with Mastebolin (vial) but estrogenic side effects are not something to worry about. Mastebolin itself acts as an anti-estrogen. There are some common and very mild androgenic side effects like acne on the face, oily skin, aggressive behaviour and increased libido. Virilization effects are also possible but still many women prefer this steroid and take this at a lower dose to avoid side effects. The Virilization effects can become permanent if proper medical attention is not provided to them.
Dose Mastebolin (vial)
The recommended and highly operative dose for males is 300-600mg per week and the cycle duration is 6 to 8 weeks. The women should take a lower dose like 100 to 300mg in a week.